Skip to content

Oscar Health OSCR Reinsurance ceding commissions

Other financials

Income statement

See full
Revenue$4.6B+52.6%
Operating income$704.1M+137%
Net income$679.0M+147%
EPS (diluted)$2.07+125%

Balance sheet

See full
Cash & equivalents$4.8B+114%
Total debt$430.9M+43.7%
Total equity$1.7B+24.8%
Total assets$9.3B+59.0%

Cash flow

See full
Operating cash flow$2.6B+198%
CapEx$8.8M-2.6%
Free cash flow$2.6B+200%

Valuation

See full
Market cap$8.56B+4.0%
Enterprise value$4.16B-174%
P/S0.6×-0.2×

Profitability

See full
Operating margin0.1%
Net margin-0.3%
FCF margin-8.2%

Returns & leverage

See full
Return on equity-2.6%
Debt / equity0.3×0.0×
Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept oscr:ReinsuranceRecoverableCededCommissions.

The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's reinsurance ceding commissions.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oscar Health's reinsurance ceding commissions?
Oscar Health (OSCR) reported reinsurance ceding commissions of $7M in Q1 2026.
How has Oscar Health's reinsurance ceding commissions changed year-over-year?
Oscar Health's reinsurance ceding commissions increased by 0.0% year-over-year, from $7M to $7M.
What is the long-term trend for Oscar Health's reinsurance ceding commissions?
Over 3 years (2022 to 2025), Oscar Health's reinsurance ceding commissions has grown at a -45.3% compound annual growth rate (CAGR), from $42.81M to $7M.